The enzyme produced by IDH1 is pivotal in a key stage of the citric acid cycle; its mutation can trigger the abnormal accumulation of 2-hydroxyglutarate, resulting in the CpG island methylation phenotype and heightened histone methylation in glioma, which are deemed as critical early events in LGG (57). Here, IDH1 is linked to central nervous system cancer.